How Quickly Do Ezetimibe and Vascepa Lower Cholesterol?
Ezetimibe starts reducing LDL cholesterol within 2 weeks, with maximum effects around 4-6 weeks at full dose (10 mg daily). Vascepa (icosapent ethyl) lowers triglycerides within 1-2 weeks, peaking at 4 weeks or more with continued use (4 g daily). Combined, patients often see triglyceride drops first, followed by broader lipid improvements.[1][2]
What Lab Changes Occur Week by Week?
- Week 1-2: Vascepa cuts triglycerides by 10-20%; ezetimibe begins modest LDL reduction (15-20% total drop expected).
- Week 4: Full triglyceride lowering from Vascepa (20-30% average); ezetimibe hits steady LDL effects.
- Beyond 4 weeks: Sustained benefits, with some seeing cardiovascular risk reductions over months in trials like REDUCE-IT for Vascepa.[1][3]
Track via blood tests at 4-12 weeks, as doctors recommend.
Factors That Affect Time to Results
Age, diet, exercise, baseline lipids, and statins (often paired with these) influence speed. High triglycerides respond faster to Vascepa; stubborn LDL takes ezetimibe longer if not combined with statins. Liver function or diabetes can delay effects.[1][2]
When Should You Follow Up with Your Doctor?
See results on labs after 4-6 weeks. If no change, dose adjustments or adds like statins may be needed. No response by 12 weeks warrants review for adherence or alternatives.[1]
Common Side Effects During the Wait
Mild issues like muscle aches (ezetimibe) or fishy taste/bleeding risk (Vascepa) appear early but rarely stop benefits. Most tolerate well long-term.[2][3]
[1]: FDA Label: Ezetimibe (Zetia)
[2]: FDA Label: Vascepa
[3]: REDUCE-IT Trial (NEJM)